samedan logo
 
 
 
spacer
home > pmps > summer 2008 > seeking closure
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Seeking Closure

With growing concerns of interactions between drug products and container closure systems, pharmaceutical companies desire an ideal elastomeric closure. Prior to this increased awareness, the role of elastomeric closures was quite basic. This allowed pharmaceutical companies to develop standard packaging components for their portfolio of injectable drug products. The role of a standard elastomeric closure was limited to confining a pharmaceutical within a given area (for example, vial or syringe), maintaining a seal for vials or syringes, and permitting proper removal of pharmaceuticals via a hypodermic needle.

However, in recent decades, more demands come from pharmaceutical companies to their suppliers, including improved compounds and coatings, more specific closures designs, manufacturing facilities that are GMP-compliant, and validated wash processes that comply with the requirements of FDA and EU guidances. This article discusses the choices pharmaceutical companies are required to review when selecting an elastomeric closure.

CLOSURE DESIGN

Typically, one of the most fundamental decisions to make when choosing an elastomeric closure is the geometrical design. This statement holds true for vial stoppers (includes serum and lyophilisation stoppers) more than it does for syringe components (plungers/pistons, tip caps and needle covers). Vial stoppers are traditionally designed in accordance with ISO standards ISO 8362-2 and ISO8362-5, which promotes compatibility with ISO standard ISO 8362-1 for vials.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Douglas Cusato is a Technical Support Manager with Helvoet Pharma. He joined Helvoet Pharma in August of 2006 and is responsible for assisting customers with technical issues such as extractables and leachables, rubber formulation and closure design recommendations, and closure coatings. He holds a Bachelor degree in Chemistry from Rutgers University, Camden, NJ, with an emphasis on biochemistry. Commencing September 2007 he began his Masters degree at Rutgers University, Camden, NJ focusing on polymer/material chemistry.
spacer
Douglas Cusato
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma enters into Development and Manufacturing Agreement with Synklino

Vilnius, Lithuania, and Copenhagen, Denmark – December 18th 2019 – Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Synklino, a company active in developing a therapeutic protein based therapy as treatment for cytomegalovirus (CMV) infection, announced today that they entered into a Development and Manufacturing Agreement for the recombinant fusion protein SYNx, which Synklino aims to bring into clinical trials.
More info >>

White Papers

Investigator Portals: Facilitating and Streamlining Communication & Collaboration with Study Sites

ArisGlobal

ArisGlobal LLC Investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management. Learn about five key areas of sponsor-investigator site interactions deserving of electronic communication and collaboration. Technology and design aspects are also covered.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement